https://www.medscape.com/viewarticle/gene-signature-outperforms-clinical-staging-cutaneous-scc-2026a1000e77
A novel gene expression signature is able to distinguish between metastasizing and nonmetastasizing cutaneous squamous cell carcinoma (cSCC) in patients identified as having low-risk disease by standard clinicopathological staging systems.
No hay comentarios:
Publicar un comentario